Burkly Linda (CIK 1985604) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-04). Recent activity: Sell EDIT (709 shares), Sell EDIT (4,928 shares), Sell EDIT (731 shares), Sell EDIT (749 shares), Sell EDIT (713 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-04 | Editas Medicine, Inc. (EDIT) | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 709 | $2,153 |
| 2026-07-29 | Editas Medicine, Inc. (EDIT) | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 4,928 | $13,158 |
| 2026-06-05 | Editas Medicine, Inc. (EDIT) | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 731 | $1,974 |
| 2026-03-04 | Editas Medicine, Inc. (EDIT) | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 749 | $1,513 |
| 2025-12-04 | Editas Medicine, Inc. (EDIT) | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 713 | $1,533 |
| 2025-09-04 | Editas Medicine, Inc. (EDIT) | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 710 | $1,846 |
| 2025-08-04 | Editas Medicine, Inc. (EDIT) | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 5,121 | $12,751 |
| 2025-06-04 | Editas Medicine, Inc. (EDIT) | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 726 | $1,249 |
来源：SEC Form 4 申报文件 · 截至 2026-09-04